these results indicate that for ideal myocardial protection the cardioplegic solution should be infused while the heart is beating under cardiopulmonary bypass , and that ventricular fibrillation induced and maintained prior to cross-clamping may cause myocardial damage .
C0018787
heart
C0027061
myocardial